BiotechTube
Home/Biomea Fusion/Juan Pablo Frías, M.D.
JP

Juan Pablo Frías, M.D.

Chief Medical Officer

Biomea Fusion

Therapeutic Areas

DiabetesObesity

Biomea Fusion Pipeline

DrugIndicationPhase
Icovamenib (BMF-219)Type 2 Diabetes (Insulin-Deficient)Phase 2
BMF-650Obesity / Metabolic DiseasePreclinical

Leadership Team at Biomea Fusion

MH
Mick Hitchcock, Ph.D.
Interim Chief Executive Officer and Board Member
RD
Ralph DeFronzo, M.D.
Key Opinion Leader / Scientific Advisor
View full Biomea Fusion profile